World Rabies Day: Boehringer Ingelheim fights rabies misconceptions 

Ingelheim, Germany,

  • Boehringer Ingelheim again joins efforts to fight rabies under this year’s theme for World Rabies Day by GARC: “Rabies: Facts, not Fear”
  • Boehringer Ingelheim strives to raise awareness of the disease and its prevention

Ingelheim, Germany, September 28, 2021 – Today on World Rabies Day, we commemorate the death of Louis Pasteur who developed the first rabies vaccine, laying the foundations for rabies prevention. The COVID-19 pandemic has resulted in an upsurge of anti-vax and anti-science movements, yet vaccination and awareness can save lives. This is why the Global Alliance for Rabies Control (GARC) has chosen the theme “Rabies: Facts, not Fear” for World Rabies Day 20211, a notion Boehringer Ingelheim fully supports through longstanding action. The company, a global leader in animal health, furthers education and the transmission of crucial knowledge about rabies while developing and supplying lifesaving vaccines. 

“Rabies is an extremely dangerous disease, but one we can eliminate through cooperation, especially on awareness and education which are just as important as vaccines,” shares Jean Scheftsik de Szolnok, Member of the Board of Managing Directors with responsibility for Animal Health. “The lives of people and animals are interconnected in deep and complex ways. A disease like rabies, from which we can best protect humans by immunizing animals, is exemplary to highlight that. In order to deliver an effective vaccination campaign, we need a collaborative and transdisciplinary approach among veterinarians, physicians but also environmentalists as well as governments, the private sector, associations and institutions.”

Three key facts about rabies anyone should know

As World Rabies Day, observed annually on September 28, is a pivotal day to draw attention to rabies control, let’s highlight three important facts about the disease subject to popular myths.

  1. We can’t afford to underestimate vaccine-preventable diseases like rabies
    Medical advances, better availability of healthcare and vaccination has led to many people not seeing vaccine-preventable diseases as a problem, which can result in vaccine hesitancy and even hostility2. In addition to this broader issue, rabies prevention is often underprioritized and underfunded5. As a result, 59,000 people still die from rabies every year, even as the disease is 100% preventable through vaccination1. By keeping firm in our efforts against rabies, the global community can save countless lives - of humans and animals alike.

  2. Rabies concerns all of us, including those who live outside of Asia and Africa
    It is true that nowadays, 95 percent of human rabies cases occur in Asia and Africa3. However, the disease can still pose a threat to people and animals living in the Americas, Europe, and Oceania. The reason is that wild animals are reservoirs of the disease even while ongoing vaccination campaigns provide thorough protection for humans and pets. If vaccination efforts let up, there is a risk of the disease being reintroduced. Human rabies cases can be eliminated, but the disease cannot be eradicated4.

  3. Stray dogs are not the only animals that pose a risk of infection to humans
    Although dogs contribute up to 99 percent of all rabies transmissions to humans5, any rabid mammal can cause an infection, including unvaccinated pets and wild animals. That is why vaccinating both pets (even indoor) and wild animals are essential to rabies elimination. According to the World Organisation for Animal Health (OIE), the vaccination of stray and owned dogs should be the first priority. The organization further notes that wildlife vaccination has produced excellent results in certain species and regions6. In countries that have successfully achieved herd immunity at a vaccination rate of at least 70 percent of the entire dog population, human rabies cases may still occur, if rarely. The Centers for Disease Control and Prevention (CDC) for example report one or two human deaths each year in the U.S. due to travel abroad or exposure to wildlife, with the most common source being bats7.

Contributing towards global rabies control

Nigel Swift, Global Head of Veterinary Public Health at Boehringer Ingelheim, relays: “At least 59,000 people die every year due to rabies8, and 40 percent people bitten by an animal suspected of carrying rabies are children5. The World Health Organization suspects that these dramatic numbers are a gross underestimation9. These facts underpin our One Health mission. At Boehringer Ingelheim’s Veterinary Public Health Center, we are proud to partner with health authorities, governments and NGOs in planning mass vaccination campaigns, as well as providing affordable global access to our high-quality vaccines to support effective rabies control.”

Sophie Randoux, Global Head of Pet Vaccine Marketing, adds: “Boehringer Ingelheim supplies more than 100 million doses of rabies vaccines each year, a feat we are very proud of. In addition to supplying governments and international organizations, we serve numerous private veterinary clinics so that pet owners can protect their pets. Beyond vaccines, we supply clinics with a range of educational materials to help veterinarians inform the general public and provide them with lifesaving knowledge. It is very rewarding to be part of the global movement aiming at ending human deaths from rabies. We are committed to continuing our joint efforts to keep people and animals safe from rabies.”

About World Rabies Day

World Rabies Day, held on September 28 every year, was initiated by GARC in 2007 to create a global opportunity for people to unite in increasing awareness of rabies prevention. Since then, it has grown year on year, with thousands of people organizing and participating in local, regional and national events, on or around September 28. Learn more at http://rabiesalliance.org/world-rabies-day

About the Global Alliance for Rabies Control

The Global Alliance for Rabies Control (GARC) is the leading non-profit organization that aims to eliminate deaths from dog rabies by 2030. GARC works with governments, veterinary, public health and educational experts, and communities to facilitate policy change and build capacity to eliminate rabies in areas hardest hit by the disease. For more information about rabies and GARC’s work, visit https://rabiesalliance.org

Boehringer Ingelheim Animal Health

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 9,700 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.

Respect for animals, humans and the environment are at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases.

Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 billion euros in 2020 and presence in more than 150 countries. For more information visit: www.boehringer-ingelheim.com/animal-health/overview.

Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com.

Intended audiences:

This press release is issued from our Corporate Headquarters in Ingelheim, Germany and is intended to provide information about our global business. Please be aware that information relating to the approval status and labels of approved products may vary from country to country, and a country-specific press release on this topic may have been issued in the countries where we do business.

References

1https://rabiesalliance.org/news/world-rabies-day-2021-theme  
2 https://www.historyofvaccines.org/content/blog/who-top-ten-threat-vaccine-hesitancy
3 https://www.afro.who.int/health-topics/rabies#:~:text=Africa%20and%20Asia%20have%20the,been%20broken%20in%20this%20region
4 https://pubmed.ncbi.nlm.nih.gov/18634470/
5 https://www.who.int/news-room/fact-sheets/detail/rabies 
6 https://www.oie.int/en/disease/rabies/#ui-id-6 
7 https://www.cdc.gov/rabies/bats/education/index.html 
8 https://www.who.int/news/item/03-05-2021-oral-rabies-vaccine-a-new-strategy-in-the-fight-against-rabies-deaths 
9 https://www.who.int/activities/improving-data-on-rabies/rabies-epidemiology-and-burden

Media Contacts

Services

Print this page

Tags

Press Release Subscription

Sign up here to the Boehringer Ingelheim Newsletter to receive press releases via email.

Related Content

Animal Health: Our Responsibility

Info hub: Sustainably fighting rabies

Did you know that every nine minutes, rabies takes a human life? Find out how we support the elimination of this deadly disease.